151 related articles for article (PubMed ID: 10609697)
21. Galantamine treatment of vascular dementia: a randomized trial.
Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
[TBL] [Abstract][Full Text] [Related]
22. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu.
Zhang ZX; Zahner GE; Román GC; Liu J; Hong Z; Qu QM; Liu XH; Zhang XJ; Zhou B; Wu CB; Tang MN; Hong X; Li H
Arch Neurol; 2005 Mar; 62(3):447-53. PubMed ID: 15767510
[TBL] [Abstract][Full Text] [Related]
23. [Comparative study on the clinical features of Alzheimer's disease and vascular dementia].
Chen X; Zhang ZX; Huang JB; Wen HB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):122-7. PubMed ID: 15171546
[TBL] [Abstract][Full Text] [Related]
24. Defining dementia: clinical criteria for the diagnosis of vascular dementia.
Román GC
Acta Neurol Scand Suppl; 2002; 178():6-9. PubMed ID: 12492785
[TBL] [Abstract][Full Text] [Related]
25. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
[TBL] [Abstract][Full Text] [Related]
26. The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study.
Sachdev PS; Lipnicki DM; Crawford JD; Brodaty H
Eur J Neurol; 2019 Sep; 26(9):1161-1167. PubMed ID: 30927497
[TBL] [Abstract][Full Text] [Related]
27. Propentofylline for dementia.
Frampton M; Harvey RJ; Kirchner V
Cochrane Database Syst Rev; 2003; (2):CD002853. PubMed ID: 12804440
[TBL] [Abstract][Full Text] [Related]
28. Nimodipine in subcortical vascular dementia trial.
Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
[TBL] [Abstract][Full Text] [Related]
29. Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.
Bastos Leite AJ; van Straaten EC; Scheltens P; Lycklama G; Barkhof F
Stroke; 2004 Feb; 35(2):415-9. PubMed ID: 14726554
[TBL] [Abstract][Full Text] [Related]
30. Placebo-controlled trial of the xanthine derivative propentofylline in dementia.
Möller HJ; Maurer I; Saletu B
Pharmacopsychiatry; 1994 Jul; 27(4):159-65. PubMed ID: 7972348
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia.
Gold G; Giannakopoulos P; Montes-Paixao Júnior C; Herrmann FR; Mulligan R; Michel JP; Bouras C
Neurology; 1997 Sep; 49(3):690-4. PubMed ID: 9305324
[TBL] [Abstract][Full Text] [Related]
32. Impact of applying NINDS-AIREN criteria of probable vascular dementia to clinical and radiological characteristics of a stroke cohort with dementia.
Tang WK; Chan SS; Chiu HF; Ungvari GS; Wong KS; Kwok TC; Mok V; Wong KT; Richards PS; Ahuja AT
Cerebrovasc Dis; 2004; 18(2):98-103. PubMed ID: 15218273
[TBL] [Abstract][Full Text] [Related]
33. Impaired attention function based on the Montréal Cognitive Assessment in vascular dementia patients with frontal hypoperfusion: The Osaki-Tajiri project.
Akanuma K; Meguro K; Kato Y; Takahashi Y; Nakamura K; Yamaguchi S
J Clin Neurosci; 2016 Jun; 28():128-32. PubMed ID: 26778514
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological validation study of four sets of clinical criteria for vascular dementia.
Gold G; Bouras C; Canuto A; Bergallo MF; Herrmann FR; Hof PR; Mayor PA; Michel JP; Giannakopoulos P
Am J Psychiatry; 2002 Jan; 159(1):82-7. PubMed ID: 11772694
[TBL] [Abstract][Full Text] [Related]
35. Dementia with cerebrovascular disease: the benefits of early treatment.
Schindler RJ
Eur J Neurol; 2005 Oct; 12 Suppl 3():17-21. PubMed ID: 16144533
[TBL] [Abstract][Full Text] [Related]
36. Comparability of the clinical diagnostic criteria for vascular dementia: a critical review. Part I.
Wiederkehr S; Simard M; Fortin C; van Reekum R
J Neuropsychiatry Clin Neurosci; 2008; 20(2):150-61. PubMed ID: 18451186
[TBL] [Abstract][Full Text] [Related]
37. Neuroradiological findings in vascular dementia.
Guermazi A; Miaux Y; Rovira-Cañellas A; Suhy J; Pauls J; Lopez R; Posner H
Neuroradiology; 2007 Jan; 49(1):1-22. PubMed ID: 17115204
[TBL] [Abstract][Full Text] [Related]
38. The diagnosis of vascular dementia in the light of the new criteria.
Amar K; Wilcock GK; Scott M
Age Ageing; 1996 Jan; 25(1):51-5. PubMed ID: 8670529
[TBL] [Abstract][Full Text] [Related]
39. Patient populations in clinical studies of donepezil in vascular dementia.
Pratt RD
Int Psychogeriatr; 2003; 15 Suppl 1():195-200. PubMed ID: 16191240
[TBL] [Abstract][Full Text] [Related]
40. Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.
Saletu B; Möller HJ; Grünberger J; Deutsch H; Rössner M
Neuropsychobiology; 1990-1991; 24(4):173-84. PubMed ID: 2135708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
